GUARD THERAPEUTICS
Guard Therapeutics develops innovative drugs for the treatment of oxidative stress and acute kidney disease.
GUARD THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2008-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.guardtherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+46 46-286 50 30
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Nginx Visa Shutterstock Craft
Similar Organizations
Halo Therapeutics
Halo Therapeutics develops antivirals to prevent users from sickness.
Official Site Inspections
http://www.guardtherapeutics.com Semrush global rank: 5.99 M Semrush visits lastest month: 1.37 K
- Host name: 188-126-67-242-static.glesys.net
- IP address: 188.126.67.242
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Guard Therapeutics"
Guard Therapeutics
Feb 20, 2025 Guard Therapeutics är ett svenskt bioteknikbolag i klinisk fas som identifierar och utvecklar nya terapier mot sjukdomar med ett stort medicinskt behov, med fokus på olika …See details»
About Guard Therapeutics
The fight against kidney disease. Guard Therapeutics is a Swedish biotechnology company developing innovative drugs in areas with significant medical needs, with a particular focus on kidney disease.See details»
Guard Therapeutics - Crunchbase Company Profile & Funding
Organization. Guard Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone …See details»
Guard Therapeutics International AB Company Description - Stock …
Mar 17, 2025 Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney …See details»
Guard Therapeutics - LinkedIn
Guard Therapeutics is developing innovative therapies focusing on kidney diseases. The company's lead clinical asset, RMC-035, is in phase 2b development for the prevention and treatment of kidney ...See details»
Guard Therapeutics - 2025 Company Profile - Tracxn
4 days ago Guard Therapeutics - Developer of drugs for acute kidney disease. Raised a total funding of $11.1M over 1 round from 4 investors. Guard Therapeutics has 112 competitors.See details»
Guard Therapeutics - Portfolio Company Profile, Executives and …
See Guard Therapeutics's complete profile, including its private equity owner and the number of its executive contacts in our database. Guard Therapeutics is a biotech company that …See details»
Guard Therapeutics - Craft
Guard Therapeutics International (formerly A1M Pharma) is a company developing drugs for the treatment of serious kidney diseases. Its biological drug candidate, ROSgard, mimics the …See details»
Guard Therapeutics - PitchBook
Guard Therapeutics General Information Description. Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful …See details»
Guard Therapeutics
Oct 17, 2024 Guard Therapeutics is a Swedish clinical-stage biotechnology company that identifies and develops new therapies for diseases with a large unmet medical need, focusing on different forms of kidney disease.See details»
Guard Therapeutics International AB (publ) (GUARD.ST) - Yahoo …
See the company profile for Guard Therapeutics International AB (publ) (GUARD.ST) including business summary, industry/sector information, number of employees, business summary, …See details»
Guard Therapeutics - Overview, News & Competitors - ZoomInfo
Guard Therapeutics contact info: Phone number: +46 86706551 Website: www.guardtherapeutics.com What does Guard Therapeutics do? Guard Therapeutics is a …See details»
Guard Therapeutics International AB (publ) (GUARD.ST)
Guardtherapeutics.com --Full Time Employees. December 31. Fiscal Year Ends. Healthcare . Sector. Biotechnology . Industry. More about Guard Therapeutics International AB (publ)See details»
Two-thirds of patients enrolled in Guard Therapeutics' Phase 2b …
1 day ago Tobias Agervald, CEO Telephone: +46 8 670 65 51 E-mail: [email protected] About Guard Therapeutics Guard Therapeutics is a Swedish …See details»
Guardian Therapeutics
Aptamers are short nucleic acids that fold into distinct tertiary structures in order to recognize specific target molecules; At the molecular level, aptamers bind to their target site through …See details»
guardtherapeutics.com – Funding, Valuation, Investors, News
Nov 11, 2022 Essential stats, news, real-time insights on guardtherapeutics.com. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
Guard Therapeutics International AB (publ) - FT.com
5 days ago Guard Therapeutics International AB (publ), formerly A1M Pharma AB, is a Sweden-based company, which is active within the healthcare sector. The Company conducts …See details»
Press releases - Guard Therapeutics
Jan 8, 2025 Guard Therapeutics today announced that it has reached the important milestone of enrolling 25% of its target in the phase 2b POINTER study. This trial is evaluating the kidney …See details»
Pressmeddelanden - Guard Therapeutics
Guard Therapeutics meddelade idag att en oberoende säkerhetskommitté (Data Safety Monitoring Committee, DSMC) har genomfört den första planerade granskningen av …See details»
Guard Therapeutics rapporterar positiva resultat från fas 1b-studie
Tobias Agervald, vd Telefon: +46 8 670 65 51 E-post: [email protected] Om Guard Therapeutics Guard Therapeutics är ett läkemedelsbolag som identifierar och utvecklar nya …See details»